Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NASDAQ:INO / Inovio Pharmaceuticals, Inc. - Short Interest, Short Volume, Short Squeeze
Security INO / Inovio Pharmaceuticals, Inc. (45773H201)
Latest Market Date 2020-05-27
Short Volume 7,781,628
Market Volume 25,674,400
Short Volume Ratio 30%
Overview
Short Interest
Short Interest is the total number of open short positions of a security. A Short Squeeze is when a company with a high degree of short interest increases in price, which forces short sellers to "cover" their short interest buy buying actual shares, which in turn drives the price up even further.
Date Short Interest Days to Cove
No data available
Short Volume
INO / Inovio Pharmaceuticals, Inc. short volume is shown in the following chart. Short Volume is a data set that can be used to understand investor sentiment. When an investor makes a short sale, they do so with the belief that a security will decline in price. If the short sale volume increases as a percentage of the total volume, then that suggests a bearish (negative) sentiment by the market. If short sale volume decreases as a percentage of total volume, then that suggests a bullish (positive) sentiment.
https://fintel.io/ss/us/ino
"PEACE"
Pure Energy Minerals Commences Drilling at the Clayton Valley Lithium Project
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2020) - Pure Energy Minerals Limited (TSXV: PE) (OTCQB: PEMIF) (the "Company" or "Pure Energy") is pleased to report that drilling of hole CV-09 has commenced at its 100%-held Clayton Valley lithium brine project ("CV Project") located in Esmeralda County, Nevada.
Schlumberger Technologies Corporation ("SLB") is Pure Energy's strategic partner at Clayton Valley and is operator of the program. Drill hole CV-09 is a new, previously permitted hole which will provide initial lithium brine samples for chemical testing by SLB. In January 2019, Pure Energy received approval from the Nevada Department of Water Resources ("NDWR") for a 50 acre-foot Finite Term Water Right permit, which is sufficient for planned testing.
The lithium-bearing brines identified at the Clayton Valley Project are of high quality with very low impurity levels. Pure Energy published a Preliminary Economic Assessment study ("PEA") for the CV Project (news releases of June 26, 2017 and April 6, 2018) which details the Project's drilling results, brine testing and resource calculation for a partial area of the CV project.
In May of 2019, Pure Energy and SLB signed an Earn-In agreement over the CV Project which requires significant investment by SLB at the Project, to include the design and construction of a pilot plant capable of processing lithium-bearing brines for high-quality lithium hydroxide monohydrate ("lithium hydroxide" or "LiOH·H2O") and/or lithium carbonate products at a specified rate. SLB plans to utilize both in-house and commercially available technology in the design of the CV pilot plant. SLB's costs, technical parameters and ultimate technology are anticipated to differ from the published PEA.
For further details regarding SLB's participation, please refer to Pure Energy's Annual General and Special Meeting Management Information Circular dated April 4, 2019, available on Sedar.com.
"Pure Energy is excited that drilling is in progress at the Clayton Valley Project once again. Our partner, Schlumberger, is advancing the regulatory and technical aspects of the CV Project towards their objective of pilot plant construction and brine testing. We plan to make additional updates in the coming months," stated Mary Little on behalf of Pure Energy.
About Pure Energy
Pure Energy Minerals is a lithium resource developer that is driven to become a low-cost supplier for the growing lithium battery industry. Pure Energy has consolidated a pre-eminent land position at its Clayton Valley Project in the Clayton Valley of central Nevada for the exploration and development of lithium resources, comprising 948 claims over 23,360 acres (9,450 hectares), representing the largest mineral land holdings in the valley. Pure Energy's Clayton Valley Project adjoins and surrounds on three sides the Silver Peak lithium brine mine operated by Albemarle Corporation.
The Company has completed a Preliminary Economic Assessment for the Clayton Valley Project (news releases of June 26, 2017 and April 6, 2018) which includes an updated resource calculation and a preliminary economic evaluation. The economic analysis presented in the PEA is based upon inferred mineral resources only. Mineral resources that are not mineral reserves do not have demonstrated economic viability. The PEA is preliminary in nature and includes inferred mineral resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves. There is no certainty that the Project envisioned by the PEA will be realized.
On January 3, 2019, the Nevada Division of Water Resources ("NDWR") approved and granted a Finite Term Water Right to Pure Energy, through its wholly-owned subsidiary Esmeralda Minerals LLC, for the extraction of up to 50 acre-feet of water during a 5-year period from the CV properties. This water right is deemed sufficient for brine testing requirements and SLB's future pilot plant facility.
Quality Assurance
Walter Weinig, Professional Geologist and Qualified Person as designated by the Mining and Metallurgical Society of America (MMSA registration #01529QP), is a qualified person as defined by National Instrument 43-101 - Standards of Disclosure for Mineral Projects and supervised the preparation of the scientific and technical information that forms the basis for this news release. Mr. Weinig is not independent of the Company, as he is a former officer.
On behalf of the Board of Directors,
"Mary L. Little"
Director, Pure Energy Minerals Limited
CONTACT:
Pure Energy Minerals Limited (www.pureenergyminerals.com)
Email: info@pureenergyminerals.com
Telephone - 604 608 6611
Cautionary Statements and Forward-Looking Information
The information in this news release contains forward looking statements that are subject to a number of known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those anticipated in our forward-looking statements. Factors that could cause such differences include: changes in world commodity markets, equity markets, costs and supply of materials relevant to the mining industry, change in government and changes to regulations affecting the mining industry. Forward-looking statements in this release may include future exploration and development on the CV Project. Although we believe the expectations reflected in our forward-looking statements are reasonable, results may vary, and we cannot guarantee future results, levels of activity, performance or achievements.
The Company does not undertake to update any forward-looking information, except as required by applicable laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56088
https://finance.yahoo.com/news/pure-energy-minerals-commences-drilling-133000926.html
"PEACE"
A COVID-19 Strategy: Invest in Companies That Are Doing Good
In this time of pandemic, investors can do well by seeking out companies that are doing good.
https://www.fool.com/investing/2020/05/11/a-covid-19-strategy-invest-in-companies-that-are-d.aspx
GO NVAX
"PEACE"
Why Novavax Shares Are Soaring Today
The most likely reason? Anticipation.
What happened
Shares of Novavax (NASDAQ:NVAX) were soaring 12.1% higher as of 11:14 a.m. EDT on Monday. The biotech didn't announce any new developments today or over the weekend. However, the most likely reason behind the stock's surge is the news that's on the way: Novavax will provide its first-quarter update after the market closes today.
So what
To be sure, investors probably aren't champing at the bit to find out Novavax's first-quarter financial results. The company doesn't have any products on the market yet, so its financials usually aren't all that meaningful -- other than its cash position. However, there are two things that investors are almost certainly eager to learn about in Novavax's Q1 conference call this evening.
The biotech reported great results in March from its late-stage clinical study of experimental flu vaccine NanoFlu. Novavax's management team is likely to discuss plans for filing for regulatory approval of the vaccine on the conference call. Investors will be very interested to hear the timeline for this filing and a potential launch for NanoFlu if it wins FDA approval.
The other item of high interest for Novavax is its COVID-19 vaccine program. In April, the company announced that it planned to begin a phase 1 study of its experimental coronavirus vaccine NVX-CoV2373 in mid-May. Look for Novavax to spend plenty of time talking about this study in the conference call later today.
Now what
What happens next for Novavax depends in large part on what the company says about the next steps for NanoFlu and NVX-CoV2373. That's why today's Q1 update is so important. The biotech stock has skyrocketed more than 400% so far this year. Good news in the Q1 conference call could send Novavax's shares even higher.
Is This the Best Coronavirus Stock to Buy Now?
This biotech company has more than its potential COVID-19 vaccine going for it.
Novavax (NASDAQ:NVAX) is a small-cap biotech company that has been at the forefront of the development of a vaccine for COVID-19. The company's shares are up by a whopping 500% since the beginning of the year, easily outpacing the return of the S&P 500, which is down by 11.5% year to date.
Investors are hopeful that Novavax will make a fortune off its potential vaccine for COVID-19. However, as several other biotech companies are looking to develop vaccines or treatments for COVID-19, betting that Novavax will win that race is a bit speculative at this point. Still, there is another potential catalyst for Novavax on the way, and this arguably makes the company worth a second look.
Novavax's NanoFlu vaccine could be a significant growth driver
Novavax focuses on the development of vaccines for infectious diseases. The company does not currently have any products on the market, but one of its lead pipeline candidates is a potential flu vaccine called NanoFlu, which is being developed specifically for adults over the age of 65.
Of course, there are other vaccines for the flu on the market, but Novavax argues that its NanoFlu has a chance to be more effective than some of the current market leaders. For instance, in a clinical trial pitting NanoFlu against Sanofi's (NASDAQ:SNY) flu vaccine Fluzone HD -- which is currently the leading flu vaccine for older adults on the market -- NanoFlu "demonstrated significantly stronger and broader immune responses" against various strains of the flu.
Novavax recently reported positive results from a phase 3 clinical trial that tested the safety and immunogenicity (the ability to trigger an immune response in the body) of NanoFlu, and the company is now planning to submit a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its potential flu vaccine.
Novavax will seek the accelerated approval designation for NanoFlu; this expedites the FDA's approval process and is typically reserved for products that address an "unmet medical need." If all goes well for Novavax, the NanoFlu vaccine could be approved relatively soon.
Where Novavax stands in the race to develop a COVID-19 vaccine
Novavax, which had prior experience dealing with other strands of coronaviruses, was able to identify an antibody that could be effective against the SARS-CoV-2 virus that causes COVID-19.
According to the company, this vaccine candidate, called NVX-CoV2373, demonstrated high immunogenicity in preclinical trials. Novavax also claimed that NVX-CoV2373 generated effective antibodies against SARS-CoV-2 in preclinical trials. The company is planning to start human clinical trials in mid-May. With that said, Novavax is currently trailing several companies in this race. According to the World Health Organization (WHO), there are about 70 COVID-19 vaccines currently in development, and three of them have already started clinical trials.
One of these is INO-4800, which is being developed by Inovio Pharmaceuticals (NASDAQ:INO). Inovio kicked off a phase 1 clinical trial for INO-4800 in early April. This trial will include up to 40 healthy adult volunteers who will each receive two doses of the vaccine. The trial will test the safety and immunogenicity of INO-4800.
With Novavax currently trailing some of its peers in this hunt, investors shouldn't bank on the company making a fortune from its potential COVID-19 vaccine.
Should you buy?
Novavax's potential vaccine for the flu looks promising, and its efforts to develop a vaccine for COVID-19 are commendable. But the company's performance year-to-date is unsustainable in the long run.
Novavax's share price will likely decrease significantly -- that is, of course, unless the company manages to beat its peers to the punch and successfully develop a COVID-19 vaccine before any of them, which seems unlikely at this point.
In short, while Novavax may worth considering for investors willing to take a little risk, it'd be best to wait for a much more attractive entry point before even thinking about purchasing shares of this biotech stock.
https://www.fool.com/investing/2020/05/11/why-novavax-shares-are-soaring-today.aspx
GO NVAX
"PEACE"
3 Top Biotech Stocks to Buy in May
These hot biotech stocks should be near the top of your list.
You might not have noticed, but biotech stocks as a group are pretty hot right now. Over the past month, the SPDR S&P Biotech ETF has soared nearly 22%. That gain is more than three times greater than the increase for the S&P 500 Index during the same period.
But ETFs by nature include both leaders and laggards. It would be great to only invest in biotech stocks that have strong growth prospects and not those that are much riskier. There are several biotech stocks that fit the bill. Here are three that I think especially stand out as great picks to buy in May.
Test tubes with increasingly higher levels of green fluid with a green arrow sloping upward in the background.
Imagine a biotech that commands a virtual monopoly in its market. A biotech with tremendous growth potential in that market. A biotech with pipeline candidates that could be game-changers. A biotech with a boatload of cash to invest in other growth opportunities. There's no need to use your imagination: Vertex Pharmaceuticals (NASDAQ:VRTX) is such a biotech.
The company markets the only approved drugs that treat the underlying cause of rare genetic disease cystic fibrosis (CF). Vertex's lineup includes four CF drugs approved in the United States. Three of them are approved in Europe as well with the fourth awaiting approval. No other drugmaker has a CF candidate that treats the cause of the disease beyond mid-stage clinical testing.
Vertex's newest CF drug, Trikafta, won FDA approval five months earlier than scheduled, something that you'll rarely see. Assuming it wins European approval, which is a pretty good bet, Trikafta could expand the company's addressable patient population by more than 50%. Meanwhile, Vertex's recent reimbursement deals for its other CF drugs in key markets give it a nice runway for growth.
The biotech's pipeline includes another triple-drug combo for treating CF, a pain drug, and two candidates targeting rare genetic diseases alpha-1 antitrypsin deficiency (AATD) and focal segmental glomerulosclerosis (FSGS) in phase 2 testing. Vertex's early stage candidates include a gene-editing therapy targeting rare blood diseases beta-thalassemia and sickle cell disease that's being developed in partnership with CRISPR Therapeutics.
As for a boatload of cash, Vertex has a cash position of $4.2 billion. It already put some of its cash to work last year with the acquisition of Semma Therapeutics for $950 million. This deal brought Semma's potential cure for type 1 diabetes into Vertex's pipeline. The big biotech plans to advance the candidate into an early stage clinical study by early 2021.
2. Gilead Sciences
The story isn't all that different for Gilead Sciences (NASDAQ:GILD). Sure, Gilead doesn't have a virtual monopoly like Vertex does. However, the big biotech dominates the HIV market. It also has a leading market share in the hepatitis C virus (HCV) market in a duopoly with AbbVie.
Gilead has been the center of attention in 2020, though, because of its antiviral drug remdesivir. The drug recently became the first treatment for COVID-19 to win emergency use authorization from the FDA. It seems likely that remdesivir will quickly become the standard of care for treating the novel coronavirus disease.
Are there other potential game-changers in Gilead's pipeline? You bet. The company awaits U.S. and European approvals for filgotinib in treating rheumatoid arthritis. Gilead is evaluating a long-acting HIV therapy in phase 2 testing that could dramatically change how the disease is treated.
It also has a couple of potential HIV cures in early stage clinical studies. In addition, the biotech's pipeline includes promising cancer cell therapies and drugs that could potentially treat nonalcoholic steatohepatitis (NASH), a disease that currently has no approved drugs.
If you're looking for a lot of cash, Gilead certainly has it. The company reported $24.3 billion in cash, cash equivalents, and marketable securities as of March 31, 2020. That cash stockpile is a little lower now, though: Gilead acquired cancer-focused biotech Forty Seven in April for $4.9 billion.
3. Novavax
Let's now go in a much different direction. Novavax (NASDAQ:NVAX) doesn't have a monopoly. It doesn't have a lot of cash. The small biotech doesn't even have an approved drug on the market yet. But what Novavax does have in common with Vertex and Gilead is tremendous growth potential and at least one possible game-changer in its pipeline.
Novavax announced really great results in March from a late-stage study of experimental flu vaccine NanoFlu. The nanoparticle-based vaccine went head-to-head against Sanofi's approved flu vaccine FluZone Quadrivalent. And NanoFlu appeared to beat Sanofi's market-leading vaccine in the clinical trial.
Like Gilead, Novavax could be a winner in the fight against COVID-19. The company expects to begin an early stage clinical study evaluating its experimental coronavirus vaccine candidate NVX-CoV2373 within a matter of days. Preclinical testing of the vaccine demonstrated promising results.
NanoFlu could easily generate peak annual sales of more than $500 million and could become a blockbuster if it's approved. With Novavax's market cap currently only a little over $1 billion, the stock has plenty of upside potential.
Novavax is certainly riskier than either Vertex or Gilead are. But it could also be the biggest winner of the three over the next couple of years.
https://www.fool.com/investing/2020/05/10/3-top-biotech-stocks-to-buy-in-may.aspx
GO NVAX
"PEACE"
Thinking of Buying Novavax Stock? Here's What You Need to Know
Coronavirus vaccine work has put Novavax in the spotlight, but its investigational flu vaccine may be the bigger revenue driver.
Novavax (NASDAQ:NVAX) may have caught your eye in recent weeks due to its work on a coronavirus vaccine. Shares of the late-stage biotech company have surged 360% since the beginning of the year while the coronavirus outbreak pushed most of the market lower.
Coronavirus work has put Novavax in the spotlight, but if you are interested in buying the stock, what you really should know about is the company's flu vaccine. Earlier this year, Novavax said NanoFlu achieved all of its primary endpoints in a phase 3 clinical trial.
That's a turnaround from last year when Novavax's vaccine to prevent respiratory syncytial virus (RSV) in babies via maternal immunization didn't meet a primary endpoint in a phase 3 trial. While a disappointment, the company continues to discuss possibilities to bring the product to market with regulatory authorities. Still, Novavax shares sank 89% for the year.
A chance at commercialization
Now, with NanoFlu, Novavax has a solid chance at commercialization. In a trial involving adults age 65 or older, NanoFlu was compared with Sanofi's (NASDAQ:SNY) Fluzone Quadrivalent. NanoFlu demonstrated non-inferior immunogenicity, was well-tolerated by trial participants, and showed a safety profile similar to that of Fluzone. And NanoFlu outpaced its rival in measures of antibody response. The only small blemish in this report: NanoFlu showed a slightly higher level of local adverse events.
In January, the Food and Drug Administration granted the vaccine candidate fast track designation, which speeds up the review process for products that address serious illnesses or fulfill unmet needs. Novavax said it would submit the vaccine for approval through this accelerated pathway.
At the same time, Novavax is moving ahead with coronavirus work. The company recently said it identified a coronavirus vaccine candidate and plans on starting human trials by the middle of this month. The investigational vaccine produced high levels of neutralizing antibodies against the virus in animal studies. Novavax also noted a high titer level, meaning a high concentration of antibodies were produced -- an element that suggests the vaccine may work in humans.
Preliminary results in July
Now Novavax will test the vaccine candidate in about 130 healthy adults in a phase 1 trial. In July, the company expects preliminary safety results as well as data on the stimulation of immune response. The Coalition for Epidemic Preparedness Innovations has offered Novavax $4 million in initial funding for the project, and discussions about more funding are ongoing.
Though the coronavirus project is definitely getting the market's attention -- and a win here would be great for Novavax -- NanoFlu represents a stronger long-term opportunity for the company. At the moment, there are too many unknowns linked to the coronavirus. How long will the outbreak last? Will the virus return seasonally, stay around, or disappear completely? There also is the ethical question of pricing too high when selling a vaccine or treatment for a pandemic.
The flu vaccine represents a treatment area with fewer unknowns. The size of the global flu market and lasting nature of the illness -- we all know flu is around every year -- make NanoFlu a significant product for Novavax. The global flu vaccine market, at a compound annual growth rate of 7.7%, is expected to reach $7.34 billion by 2026, according to Fortune Business Insights. Sanofi reported a 100% gain in flu vaccine revenue -- that includes Fluzone and other products -- to $68 million in the first quarter.
Novavax earnings
Novavax reports earnings on May 11, and investors should be on the lookout for any news on NanoFlu's progress. It also will be important to keep an eye on Novavax's research and development expenses and costs linked to the coronavirus program. If costs go up without much outside funding, I would hesitate to invest in the shares at this point. Moderna (NASDAQ:MRNA), a rival in the race to produce a vaccine, has government funding that will take the company's vaccine through FDA licensure.
In the near term, Novavax shares may have more to gain with any good news from the coronavirus work. But for a long-term investor, I would look to regulatory news on NanoFlu before buying the shares. If the FDA gives NanoFlu the nod, this vaccine could be the true money-maker for Novavax.
Novavax (NASDAQ:NVAX) may have caught your eye in recent weeks due to its work on a coronavirus vaccine. Shares of the late-stage biotech company have surged 360% since the beginning of the year while the coronavirus outbreak pushed most of the market lower.
Coronavirus work has put Novavax in the spotlight, but if you are interested in buying the stock, what you really should know about is the company's flu vaccine. Earlier this year, Novavax said NanoFlu achieved all of its primary endpoints in a phase 3 clinical trial.
That's a turnaround from last year when Novavax's vaccine to prevent respiratory syncytial virus (RSV) in babies via maternal immunization didn't meet a primary endpoint in a phase 3 trial. While a disappointment, the company continues to discuss possibilities to bring the product to market with regulatory authorities. Still, Novavax shares sank 89% for the year.
A chance at commercialization
Now, with NanoFlu, Novavax has a solid chance at commercialization. In a trial involving adults age 65 or older, NanoFlu was compared with Sanofi's (NASDAQ:SNY) Fluzone Quadrivalent. NanoFlu demonstrated non-inferior immunogenicity, was well-tolerated by trial participants, and showed a safety profile similar to that of Fluzone. And NanoFlu outpaced its rival in measures of antibody response. The only small blemish in this report: NanoFlu showed a slightly higher level of local adverse events.
In January, the Food and Drug Administration granted the vaccine candidate fast track designation, which speeds up the review process for products that address serious illnesses or fulfill unmet needs. Novavax said it would submit the vaccine for approval through this accelerated pathway.
At the same time, Novavax is moving ahead with coronavirus work. The company recently said it identified a coronavirus vaccine candidate and plans on starting human trials by the middle of this month. The investigational vaccine produced high levels of neutralizing antibodies against the virus in animal studies. Novavax also noted a high titer level, meaning a high concentration of antibodies were produced -- an element that suggests the vaccine may work in humans.
Preliminary results in July
Now Novavax will test the vaccine candidate in about 130 healthy adults in a phase 1 trial. In July, the company expects preliminary safety results as well as data on the stimulation of immune response. The Coalition for Epidemic Preparedness Innovations has offered Novavax $4 million in initial funding for the project, and discussions about more funding are ongoing.
Though the coronavirus project is definitely getting the market's attention -- and a win here would be great for Novavax -- NanoFlu represents a stronger long-term opportunity for the company. At the moment, there are too many unknowns linked to the coronavirus. How long will the outbreak last? Will the virus return seasonally, stay around, or disappear completely? There also is the ethical question of pricing too high when selling a vaccine or treatment for a pandemic.
The flu vaccine represents a treatment area with fewer unknowns. The size of the global flu market and lasting nature of the illness -- we all know flu is around every year -- make NanoFlu a significant product for Novavax. The global flu vaccine market, at a compound annual growth rate of 7.7%, is expected to reach $7.34 billion by 2026, according to Fortune Business Insights. Sanofi reported a 100% gain in flu vaccine revenue -- that includes Fluzone and other products -- to $68 million in the first quarter.
Novavax earnings
Novavax reports earnings on May 11, and investors should be on the lookout for any news on NanoFlu's progress. It also will be important to keep an eye on Novavax's research and development expenses and costs linked to the coronavirus program. If costs go up without much outside funding, I would hesitate to invest in the shares at this point. Moderna (NASDAQ:MRNA), a rival in the race to produce a vaccine, has government funding that will take the company's vaccine through FDA licensure.
In the near term, Novavax shares may have more to gain with any good news from the coronavirus work. But for a long-term investor, I would look to regulatory news on NanoFlu before buying the shares. If the FDA gives NanoFlu the nod, this vaccine could be the true money-maker for Novavax.
https://www.fool.com/investing/2020/05/10/thinking-of-buying-novavax-stock-heres-what-you-ne.aspx
GO NVAX
"PEACE"
Been looking at it sense the $8's. Been in it sense $16's.....On the down-low making that green-thing-ring
Tesla secures $565 million loan for Shanghai factory
(Reuters) - Electric carmaker Tesla Inc has entered into an agreement for a working capital loan of up to 4 billion yuan ($565.51 million) with a lender from China for its Shanghai car plant, according to a regulatory filing on Friday.
The loan, which will be provided by Industrial and Commercial Bank of China Limited, will be used only for expenditures related to production at the Shanghai plant, the filing said.
The factory is Tesla's first car manufacturing site outside the United States and is the centerpiece of its ambitions to boost sales in the world's biggest auto market and to avoid higher import tariffs imposed on U.S.-made cars.
Tesla had suspended production at its San Francisco Bay Area plant due to the broader impact of the coronavirus, and was told by the local county health department on Friday that it "must not reopen" as local lockdown measures remain in effect.
https://www.yahoo.com/finance/news/tesla-secures-565-million-loan-215953628.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla isn't a car company, and it isn't a tech company — it's a new GE for the 21st century, and it's just getting started. Here's how it could dominate the global business world.
https://www.yahoo.com/news/tesla-isnt-car-company-isnt-125300321.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
SHO-UR-RITE!!!!
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla, Inc. (TSLA) shall continue its reign above them all.
There have never been this many electric cars on the market. Here's a rundown of the 14 you can buy right now.
https://www.yahoo.com/news/never-many-electric-cars-sale-201831166.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
YEAH RIGHT!......Go Tesla,Inc.
Ford And GM Do Not Care Much About Electric Vehicle Production
The promise that electric vehicles (EVs) hold in the automobile market hinges on two major factors – that they will decrease tailpipe emissions and they will be more economical to operate than internal combustion engine (ICE) vehicles. But as oil prices continue to stay close to a several-decade record low, the cost of operating an ICE vehicle has not been this inexpensive in recent years, making them look a lot more attractive to prospective buyers.
With analysts lowering their outlook for global oil demand in the second quarter of 2020 due to the COVID-19 epidemic, it is certain that the operating cost of ICE vehicles will be comparable to that of EVs.
The memo looks to have reached major U.S. auto companies, with detailed production plans for North America showing Ford Motor Company (NYSE: F) and General Motors Company (NYSE: GM) forecasting to produce more than five million SUVs and pickup trucks in 2026, while only planning to make 320,000 EVs the same year. These paltry EV numbers are nowhere close to holding up to the big two's often reiterated idea of an electrified auto future.
To put numbers in perspective, the production volume is only about 5% of the companies' total vehicle production in North America that year. In comparison, EV market leader Tesla Inc. (NYSE: TLSA) manufactured more cars in 2019 at its Fremont, California factory than Ford and GM plan for 2026. And even with these minuscule numbers, the EVs being produced in the U.S. by Ford and GM will mostly be exported to China, where the demand for EVs has far outstripped the rest of the world.
Thus, it is puzzling to see the auto giants publicly take a stance that looks quite different from their reality and proposed future. Executives across both Ford and GM have frequently expressed faith in a future inching towards an all-electric zero-emissions transport environment. However, if the devised plans are followed religiously, the big two will produce eight-fold the number of SUVs than traditional cars, with an overwhelming 93% of those cars being ICE vehicles.
Earlier this March, GM CEO Mary Barra stated that the company would spend $20 billion on its electric and automated vehicle programs over the next five years, with an idea of selling a million EVs a year in the U.S. and China – a statement that directly contradicts the plans set in place.
While Barra spoke of climate change and the company's aggressive move to produce EVs, GM's resolution to ramp up the scale of SUV production in the future belies its proposed intentions. Now with the price of oil tanking, the strategy might actually work well to its advantage.
However, the reason for the automakers to continue professing interest in electrification might stem from the fact that the stock market reacts positively to it. By aligning themselves with the promise of sustainability in transport, companies can hope to keep their stock value high.
A case in point is the market value of Tesla compared to that of GM. While Tesla has a market cap of nearly $96 billion, GM has a market cap of around $32 billion. This is interesting, because GM's annual revenue was more than five times that of Tesla in 2019.
And the reluctance to produce more EVs comes down to a North American auto market that has yet to adopt EVs en masse compared to China or Scandinavia. "We're trying to time this with the natural demand of consumers (so) we're not forced to do artificial things and we don't violate the laws of economics," said Hau Thai-Tang, Ford's chief product development and purchasing officer.
For now, it appears that the big two automakers are prioritizing ICE vehicles over EVs. But on a positive note, the companies have stated that they will look to improve fuel efficiency and reduce tailpipe emissions as much as possible – thus, holding on to their end of the sustainable transport promise.
https://www.yahoo.com/finance/news/ford-gm-not-care-much-155107166.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
See more from Benzinga
Let's Not Lie: GM's New Ultium Battery Isn't Better Than Tesla's
GM EV Battery Day
200-kWh and 400 miles of range is GM's claim, but Tesla has cars with a claimed range of over 620 miles.
General Motors recently revealed its all-new Ultium battery technology and immediately it was deemed by some as Tesla beating, but is that truly the case?
When GM spilled details on its new Ulitum battery, it revealed that capacity will be up to 200 kWh and range of vehicles equipped with such batteries will boast up to 400 miles of range. The numbers are impressive, but the misleading headlines make it seem as though the figures somehow trump Tesla.
More GM Ultium News
First, GM's actual statement in its press release:
Ultium energy options range from 50 to 200 kWh, which could enable a GM-estimated range up to 400 miles or more on a full charge with 0 to 60 mph acceleration as low as 3 seconds.
And here's what that evolved into in some headlines from around the web:
GM's New Electric Car Battery Tops Tesla's
Get Ready Tesla, GM Is Touting a 400-Mile Range for Electric Vehicles
GM Promises Profitable Electric Cars With Tesla-Beating Range
Those are just a few of the GM-beats-Tesla headlines. The problem is, General Motors never made such a claim and wisely never mentioned Tesla as a competitor or a target. And here's why.
Ultium-Powered Vehicles Don't Yet Exist
First off, the claims made by GM in regards to range are just that...claims. There's no vehicle with Ultium batteries in production and no vehicle with those batteries either with a range figure certified by the EPA or with real-world testing to verify those claims.
Sure, perhaps GM has tested its own setup and feels comfortable claiming 400 miles of range from a 200-kWh battery, but until an actual product enters production and gets its EPA-rated range, we have to remain cautious in regards to automaker claims.
Remember, the Porsche Taycan was originally projected to have a range of over 300 miles, but it later got EPA certified much lower. Yes, our independent Taycan tests verified it can go much further per charge than the EPA states, but that's anecdotal.
Porsche Taycan Range Rating
Porsche Taycan Turbo S EPA Range Rating Is Just 192 Miles
2020 Porsche Taycan Turbo Gets EPA Range Rating Of Just 201 Miles
Tesla Has Much Bolder Claims
400 miles of range is an impressive figure, but remember that Tesla has already stated its future vehicles will go much farther than that.
In top-spec form, the Tesla Cybertruck has a claimed range of over 500 miles from a battery pack of an undisclosed size.
500 is a lot, but guess how far Tesla says the new Roadster will go? Over 620 miles per charge.
More On Tesla's Range
Tesla Increases Model S Range To 390 Miles (Model X To 351 Miles)
Next-Gen Tesla Roadster Electric Range To Be Outrageous
Tesla's Range Today Is Nearly 400 Miles From A 100-kWh Battery Pack
Saving the best for last, the current Tesla Model S Long Range goes 390 miles per charge with a battery pack that's just half the size of the largest GM Ultium pack. Yes, that's right. Tesla's today can almost hit 400 miles on just 100-kWh of battery, so saying that GM's 200-kWh Ultium battery tops Tesla's is a statement that surely misses the mark. It's bigger, but not necessarily better.
Closing
Let's be honest though. Tesla has a product you can buy right now. GM's promised 400-miler could still be years away. Remember way back in 2017 when GM first revealed its massive EV offensive? Well, this is GM EV offensive "take two" and there's a chance it could never come to life, just like take one failed to result in the release of any groundbreaking EVs from any of General Motors' brands.
We truly hope GM pulls it off this time around, but to say GM has already topped Tesla is a statement that is far from true.
https://www.yahoo.com/autos/lets-not-lie-gms-ultium-213213043.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
...If this was a Tesla, all headlines would be a blaze, as it has been in the past. But sense it is not.
A Porsche Taycan Just Confirmed That EVs Can Go Up in Flames Too
https://www.yahoo.com/lifestyle/porsche-taycan-just-confirmed-evs-233001091.html
AND.......................
A brand-new, all-electric Porsche Taycan sport sedan caught fire in Florida over the weekend — here's what we know so far
https://www.yahoo.com/news/brand-electric-porsche-taycan-sport-182818859.html
GO FIGURE.....AND IT'S ONLY THE BEGINNING!
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla Model 3 Teardown Finds Technology Years Ahead Of Established Automakers
Tesla Inc's (NASDAQ: TSLA) core computing technology, which will allow autonomous operation, is "far ahead" of other carmakers' computing, according to a "tear-down" of the vehicle and review by Nikkei Asian Review.
The company deconstructed the Tesla Model 3, the company's $33,000 all-electric car, and said its integrated central control unit, or "full self-driving computer," sets the car apart from any on the market.
Nikkei quoted an engineer from an unnamed Japanese car maker who inspected the computer as saying it couldn't be matched by that company.
Tesla Reshapes The Supply Chain
Nikkei Asian Review touted the computer, also known as "Hardware 3," as Tesla's "biggest weapon in the burgeoning EV market" and said it could "end end the auto industry supply chain as we know it."
That's because the Tesla computer eliminates the need in the car for many of the electronic control units currently supplied to other automakers by a vast web of suppliers.
Tesla, the review said, appears to maintain a much tighter control over the components in its car.
Tesla's Easier Method Of Extending Autonomy
That's key, the article said, because it means Tesla can boost the technologic capability of the car through "over the air" software updates.
They're partially autonomous now, but Tesla CEO Elon Musk has said they have the necessary components now for full self-driving capability.
The computing component, which is in new Model S and Model X Teslas in addition to new Model 3s, includes two custom AI chips developed by Tesla on its own and special software.
The computer not only powers the Tesla's autonomous capabilities, but its in-vehichle entertainment system.
Tesla has beaten rivals, including Toyota Motor Corp. (NYSE: TM) and Volkswagen AG/ADR (OTC: VWAGY), on autonomy-capable computing power by as much as six years, the article said.
Tesla is bringing other technology development in-house, in addition to its software and computing hardware, Nikkei said.
"If this strategy succeeds, competitors will have little choice but to follow suit, upending their old business models and supply chains as they try to overcome Tesla's head start."
Tesla's Stock Price
Tesla shares were up 6.02% at publication time Tuesday, trading at $848.23.
https://www.yahoo.com/finance/news/tesla-model-3-teardown-finds-192850362.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla Files For Touchscreen Steering Wheel Patent
Tesla Inc. (NASDAQ: TSLA) has filed a patent for a new steering wheel with three touchscreens and technology that replaces the need for the gear stalk.
What Happened
The patent summary describes the steering wheel in which the user interface is provided on ‘at least one portion’ of the steering wheel.
“The user interface recognizes gesture movements made by a user and allows navigation of a set of controls associated with a menu based on the gesture movements made by the user.” Touchscreens on the steering wheel would be able to give haptic feedback.
According to the patent in vehicles that support autonomous driving inputs such as handwriting or complex gestures may be available. These types of inputs would be deemed ‘too distracting’ when used by humans, even with driver-assist functionality.
The patent application lists Felix Godard and Joris Aerts as the designer and engineer for the new concept steering wheel, according to Electrek. Godard has since left Tesla for Lucid Motors, Inc. Aerts, too, has left the company.
Why It Matters
Tesla wants more drivers to keep their hands on the wheels. The company has even added nags in the past to force that behavior.
Other manufacturers too also toyed with the idea of touchscreens in the past to keep drivers engaged with the steering wheel. Automotive technology supplier and tire manufacturer Continental AG (OTC: CTTAY) showcased touchscreen technology in 2016 that allowed for gestures instead of the usual buttons or touch-sensitive surfaces on steering wheels.
Price Action
Tesla shares traded 3.47% lower at $723.00 in the pre-market session at press time. On Thursday, Tesla shares had closed 1.94%
higher at US$748.96.
https://www.yahoo.com/finance/news/tesla-files-touchscreen-steering-wheel-123408509.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla’s Brilliant Business Strategy Could Be a Total Game Changer
Few companies have attracted as much praise, derision, scepticism and enthusiasm as Telsa Motors and its founder Elon Musk. Having interviewed Elon Musk and the Tesla leadership as part of my research, one of the questions I’m asked most frequently is: how can you make sense of Tesla’s wild strategies? The latest example is the move to create a “Gigafactory” for car batteries just outside Berlin.
Part of the challenge in understanding Tesla’s strategy are the commentators. These range from short-selling to star worship. Many ask the wrong questions, such as why Tesla isn’t making any money – a question appropriate for a mature business, but not a growth one. While all businesses must be sustainable in the long run, Tesla is like most rapid growth companies that eat up more cash flow than they produce while in the early growth phase.
But the biggest part of the challenge may simply be understanding Tesla’s strategy. Why would a new company, already taking on the Herculean task of introducing an entirely new type of car to the market, also take on the incredible risk of building some of the world’s largest battery factories? Or for that matter, a dealership and repair network? Or a charging network? Or, even crazier, a solar power business?
Read the original article.
https://nationalinterest.org/blog/buzz/tesla%E2%80%99s-brilliant-business-strategy-could-be-total-game-changer-116786
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Jim Cramer: Think of Tesla as a Tech Equity, Not an Auto Stock
What does Tesla do? It's an electronic delivery vehicle. Right now others have cars that are electrified but they are not electronic delivery companies like Tesla is. That's right, it is not a car.
The mother of all short squeezes? Or the realization that it's a tech stock with big earnings capability that happens to transport people.
That's the Tesla (TSLA) dilemma. That's what we are all trying to figure out.
First, let's take the case of the short squeeze. Eighteen percent of the stock is shorted, according to the most recent data.
While that's a lot, it is not enough to cause what we are seeing each day, including today. So, is it possible that there is more sold short than we realize?
Absolutely. It is entirely possible that there are a number of derivatives that institutional investors have used to bet against Tesla. We can't see those positions but it makes a ton of sense to use some sort of instrument besides the stock outright. When lumped in with the common stocks short they could be expected to play a big role.
That said, I am not hearing about the fabled buy-ins, where the brokers have to deliver stock to the natural buyers and have no choice but to go into the open market and buy it and credit it to you,. So if you are short 10,000 shares of Tesla, and you can't deliver the stock, you lose control of the situation and whatever broker who needs the stock can't get it from you he goes into the open market and purchases the stock.
That means he might be buying it before the stock market opens as we see every morning. I have had a buy-in and the price is nowhere near where the stock was trading the day before. In that sense it sure feels like a gigantic buy-in. But it is not something that should happen day after day after day.
No, I think it is more likely that institutional investors, once they realized that insolvency was off the table, decided to reevaluate the stock not as an auto equity but as a tech equity.
Why not?
What does Tesla do?
It's an electronic delivery vehicle. Right now others have cars that are electrified but they are not electronic delivery companies like Tesla is. That's right, it is not a car. It is a hybrid item loaded with tech that happens to get you from point a to point b. It has a seemingly endless amount of demand because it is not just an electric car. That's what keeps confusing people. Almost every car company has an electric car and almost none have any demand to speak of.
Plus, Tesla has a battery business that very well may turn out to have genuine earnings power given that batteries are the green way of the future.
Now, most people would never want to buy a tech stock that has no hope of ever making money. Only a few companies, namely, Netflix (NFLX) , Amazon (AMZN) and Tesla have earned the right to be earnings-free.
The shocking thing about Tesla is that it's about to have an earnings breakout, maybe as much as $5 this year and $10 next year. Go listen to the Netflix call last night. The company's crowing that it might one day be cash flow positive. One day!
I think that the recognition that this is Tesla's breakout year and that the breakout is coming from China because of a plant that was built in 10 months, and that there will be another plant built next year in Germany to meet European demand, gives you a roadmap for even bigger numbers in the outyears.
That means to me that all comparisons to Ford (F) and GM (GM) are fatuous. It's like saying that DRAMs should get the same multiple as micro-processors or CPUs like the kind Nvidia (NVDA) makes. So stop adding up the market caps of Ford and GM and comparing them to the market cap of Tesla.
https://realmoney.thestreet.com/jim-cramer/jim-cramer-think-of-tesla-as-a-tech-equity-not-an-auto-stock-15214742?puc=yahoo&cm_ven=YAHOO&yptr=yahoo
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Elon Musk says he plans to send 1 million people to Mars by 2050 by launching 3 Starship rockets every day and creating 'a lot of jobs' on the red planet
https://www.yahoo.com/news/elon-musk-says-plans-send-221200960.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla stock could hit $6,000 per share in the next five years, analyst says
The firm that once predicted Tesla (TSLA) shares would cross the $4,000 mark delivered a new, even more bullish price target for the electric-vehicle maker.
Shares of Tesla could be worth $6,000 each in the next five years, Ark Investment Management analyst Tasha Keeney told Yahoo Finance’s The Final Round Wednesday.
The soaring target implies a return of more than 1,000% from Tesla’s closing prices Wednesday. At $6,000 per share, Tesla’s market capitalization would leap well above the $1 trillion mark, based on shares outstanding as of its latest quarterly earnings update. Tesla’s current market capitalization is north of $90 billion, or more than that of Ford (F) and GM (GM) combined.
The $6,000 per-share level is Ark’s bull case scenario, implying a best-case situation for Tesla over the next few years.
“That’s assuming our bull case assumptions for the EV (electric vehicle) market,” Keeney said. “Broadly what’s changed in our assumptions over the past few years is, we’ve always said that Tesla was three years ahead on batteries, autonomous hardware and autonomous data collection. And really we’re adding software to that, over-the-air software updates.”
“What we’ve seen happen is really the rest of the auto market, shockingly, is really so far behind Tesla,” she added. “I mean there hasn’t been an EV produced that’s on par with the Model S which came out, you know 7-8 years ago. And so we’re just seeing it move further ahead on all of those fronts.”
Ark’s investment thesis mirrors that of some other traditional firms on Wall Street, which have recently pointed to Tesla’s troves of collected data as a launching point for future developments in autonomy.
Oppenheimer analyst Colin Rusch on Monday raised his price target on Tesla to $612 from $385, citing in part Tesla’s “600,000 cars on the road collecting data from all of their sensor suites” helping the company “redesign their autonomous system.”
The average 12-month price target on Tesla’s stock is $354.26, according to Bloomberg-compiled data on 30 firms delivering price targets over the past three months, not including Ark’s call. Shares of Tesla closed at $518.50 each on Wednesday.
Keeney noted that Ark Invest will be publishing an updated model and Tesla price target in the next few weeks.
Tesla Inc CEO Elon Musk takes off his coat onstage during a delivery event for Tesla China-made Model 3 cars in Shanghai, China January 7, 2020. REUTERS/Aly Song
Tesla Inc CEO Elon Musk takes off his coat onstage during a delivery event for Tesla China-made Model 3 cars in Shanghai, China January 7, 2020. REUTERS/Aly Song
‘Their opportunity could just run away with them’
In the past month alone, Tesla’s stock jumped nearly 50% as deliveries came online from its Shanghai Gigafactory, China’s first wholly owned car factory by a U.S. automaker.
That factory handed over its first vehicles to public customers within a year of breaking ground in Shanghai in January 2018, bringing Tesla to the world’s largest auto market at a much faster than expected pace.
“We think this is just going to accelerate that story,” Keeney said. “It’s going to help the cost structure, it’s going to help Tesla scale in a capital-efficient matter.”
And in the U.S., Keeney said she didn’t think a future where Tesla was the No. 1 domestic automaker would be such “a wild assumption, especially in the autonomous car space where it’s a winner-takes-most market.”
“We think they’re going to be able to launch an autonomous taxi service in the next few years. I think their opportunity could just run away with them,” Keene said. “And if you look at the other US automakers, I mean again their EV platforms aren’t as great and they’re really behind on the data collection that you need to get an autonomous platform off the ground.”
https://finance.yahoo.com/news/tesla-shares-could-hit-6000-in-the-next-five-years-analyst-says-222217295.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla has 'key advantage' over other automakers, analyst says
Tesla’s (TSLA) stock surged nearly 10% to a record high Monday, breaching $500 per share for the first time ever.
The sharp advance in the electric car-maker’s stock came in the wake of a bullish call from Oppenheimer analyst Colin Rusch, who bumped his price target on Tesla to $612 a share, up from $385 previously and representing one of the highest on Wall Street.
A primary tenet of Rusch’s bull thesis was rooted in his conviction that Tesla remains well ahead of its competitors in autonomous innovation.
Troves of information collected from hundreds of thousands of vehicles on the road have enabled Tesla to create a database for future developments in autonomy, Rusch said.
“They’ve got 600,000 cars on the road collecting data from all of their sensor suites, collecting what we consider ‘corner cases’ – you know, the odd lots, the unusual circumstances that a car might run into on the road,” Rusch told Yahoo Finance’s The Ticker on Monday. “And we think that data is, you know, going to help them redesign their autonomous system.”
Tesla has previously touted its use of data to improve existing features like Smart Summon, which CEO Elon Musk said in October had been used more than a million times.
“This really illustrates the value of having a massive fleet because it allows us to collect these corner cases and learn from them and use fleet learning and become rapidly better, just as Navigate on Autopilot did on the freeway,” Musk said during a call with analysts about Tesla’s third-quarter results in October. “This really is just the beginning as we collect more data and Autopilot and Full Self-Driving functionality gets better.”
Rusch, for his part, agreed with the benefits Tesla derived from scale.
“They have 600,000 cars versus the next competitor that’s between 600 to 1000 cars out there collecting data,” Rusch said. “We think that’s a key advantage.”
Rusch also cited the speed at which Tesla developed its China Gigafactory as a factor in his bullish outlook on the stock.
“The first shovel going into the ground to first vehicle was less than a year. We think that’s put a lot of the automakers on notice for an existential threat, really not just from a technology perspective but from a manufacturing perspective,” Rusch said.
That expedited time – from breaking ground on a plot of land in Shanghai in January 2019 to delivering its first vehicles built in China earlier this month – marked a major turnaround from the production woes Tesla had endured a couple years prior at its earlier major factory in Fremont, California.
While auto sales overall in China have been slowing, analysts convened on the view that getting the factory online quickly was a major win for Tesla. And that milestone added to a batch of positive developments for the company: Just days before delivering its first car, Tesla reported record fourth-quarter 2019 deliveries of 112,000 vehicles, up 23% over the year prior.
“We think they’re actually learning from those mistakes and making some real changes to their processes,” Rusch said.
https://www.yahoo.com/finance/news/tesla-has-key-advantage-over-other-automakers-analyst-says-222949813.html
—
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
5 things Tesla bears keep getting wrong about this stock
At any moment, a small group of fashionable, fast-moving investment ideas captivate Wall Street. Think marijuana stocks or the blockchain bandwagon (recall how Overstock.com jumped on that one) as prime examples of investing fads that stuffed your newsfeed for months during the last year or two .
These hyped-up themes tend to be driven by narrative, not fundamentals, and are perfect fodder for speculation. But eventually, hard facts or simple impatience takes its toll and the high-flying stocks fall out of favor.
On the surface, it’s tempting to lump in Tesla TSLA, +2.92% with other fad investment themes. It’s a wildly volatile stock, after all, and bullish investors tend to rely on storytelling and rampant speculation to backstop their call instead of traditional fundamental analysis. The fact that it’s a play on a high-tech megatrend via the global transition to electric vehicles is the icing on the cake.
However, with returns of more than 2,500% since its 2010 IPO — more than 12 times the returns of the S&P 500 index SPX, -0.29% in the same period — it’s obvious that Tesla is far more than just a fad.
This stock is the real deal, and it’s foolish to insist otherwise.
TimeTesla Inc.Mar 19May 19Jul 19Sep 19Nov 19Jan 20
US:TSLA $100$200$300$400$500$600
Sure, there are periods where the stock has declined in the short term. Equally, Tesla has given many traders whiplash lately as the stock has skyrocketed 160% from its mid-2019 lows, so it’s natural to wonder if that move has been a bit too much to be sustainable. And with a goofy CEO who sells flamethrowers to raise funds for his “hobby” of drilling massive tunnels underground, there are sure to be embarrassing headlines that weigh on the stock for legitimate reasons.
But investors scared of sticking with Tesla simply because it doesn’t play by the typical rules of Wall Street stocks are missing the point. Here’s what the bears need to understand about Tesla after its recent red-hot run, and why they may want to think twice before betting against the stock.
Tesla’s China opportunity isn’t overblown
The company’s big news lately is about its China expansion, and it’s tempting to write off the hysterical headlines as the latest pie-in-the-sky predictions about the firm’s growth potential. But before you shrug them off completely, consider this: In fiscal 2018, General Motors GM, +0.29% sold 3.6 million vehicles in China and just under 3.5 million in North America. Or better yet, take Daimler DAI, -1.59%, which sold 677,000 Mercedes-Benz vehicles in Greater China in 2018 vs. less than its 330,000 luxury cars sold in the U.S. over the same period.
You can’t just wave a magic wand and sell cars in China, of course. But this is a company that has spent every moment of the last 10 years figuring out how to build up operations including factories, supply chains and a distribution network in America. The lessons learned from this experience will surely set Tesla up for success in this new market.
Bears should think of it this way: even if Tesla’s U.S. sales flatline from here — something that is nigh impossible given current growth rates — the company may still double its sales over the next few years simply by tapping in to Greater China. That tells you all you need to know about why the stock has been on a tear lately.
Musk’s five-year-old forecast is right on schedule
Some bears like to naysay Tesla based on some rather public production delays. But despite those who warned Tesla wouldn’t actually deliver on its long-hyped promise of a mass-market Model 3, this lower-priced model accounted for a staggering two-thirds of U.S. electric vehicle sales in the second quarter of 2019. In the third quarter, Tesla delivered nearly 80,000 of the vehicles to make the Model 3 its leading product by volume now and for the forseeable future.
But more important than simply delivering on the promise of the Model 3 is that the car is one more proof point in the impressive long-term narrative of Tesla’s growth — which, by the way, is right on schedule. Consider that in 2015, despite a slew of production delays, CEO Elon Musk stuck to his goal of 500,000 units sold by 2020 — 10 times the tally of about 50,000 that year. It was a figure that many investors scoffed at but now appears to be a pretty fair forecast five years down the road as quarterly run rates are now around 100,000 total units and growing.
There will surely be future delays and setbacks. But before you roll your eyes over recent comments about how Elon Musk’s planned Model Y crossover could eclipse even the Model 3 in sales, think about how Tesla delivered on these previous and equally ambitious forecasts.
Watch this video: Here’s why the cheapest Tesla will probably cost you at least $40,000
Old price targets are just that ... old
One common refrain among the bears is that the consensus price target is well behind the actual share price of Tesla; right now, the media target is $340 — nearly 30% below present levels. But it’s important to understand price targets are created at a moment in time, and a fast-moving stock like Tesla requires constant re-evaluation.
Case in point: In 2020, we’ve already seen three major changes in Tesla targets by my tally. On Jan 2., Canaccord Genuity reiterated its buy call and boosted its target from $375 to $515 for a roughly 37% boost. Then on Jan. 7, Argus increased its target to $556 from $396 — a jump of 40%. On the same day, Credit Suisse upped its target by 70%, from $200 to $340, although it still kept its underweight recommendation.
The price targets on Tesla are moving higher, sometimes dramatically so. That means the consensus price target is steadily moving higher, too. So don’t read too much into someone’s $300 target from nine months ago, since it may soon be revised significantly higher.
Read: Why a ‘battle-weary’ Tesla enthusiast is now telling investors to move to the sidelines
Market capitalization is irrelevant
For the life of me, I don’t know why investors make such a big deal about market-cap comparisons between Tesla and legacy automakers like Ford Motor Co. F, +0.11%. How is this a relevant metric that says anything about where either stock is headed?
Raw size simply doesn’t matter — and even in the context of measuring valuation, market cap has serious shortcomings.
For instance, automaker Ferrari RACE, +0.82% is valued at $29 billion but ships a mere 2,500 vehicles a quarter. Yet there’s no hand-wringing over how Ferrari is a fad company that can’t sustain its value on such thin sales volume, or that it is simply a first-mover on sports cars that is sure to be disrupted by competitors. That’s presumably because investors understand Ferrari is a fundamentally different stock. It’s time the bears realized the same thing about Tesla.
Shorting is for suckers
Perhaps the biggest reason of all to rethink a bearish position on Tesla is that it is simply a money-losing proposition. I’m not talking on missing out on share appreciation either, but rather the bloodbath constantly caused by short-sellers taking a position against Tesla — and getting squeezed out in painful fashion.
Consider that at the end of May, short interest in Tesla peaked at just shy of 44 million shares according to Nasdaq data. But by mid-December, that figure had plummeted to just over 27 million shares.
Sure, Tesla has high enough volume to cover some of this action with the regular froth that characterizes a volatile stock. But it’s important to remember that the “float” of Tesla isn’t as large as you might presume give its 180 million total shares outstanding. Roughly 21% of the company held by insiders — and the bulk of that is in the hands of CEO Elon Musk, who has said publicly on numerous occasions that he has no interest in selling. Throw in institutional ownership of 58% on top of that and you have a steady foundation for the stock underneath the day-to-day volatility.
Occasionally, a well-timed or lucky trade makes a short seller a handy profit in Tesla. But in the long run, bears not only lose their shirts but also prove the bull case for this stock in a big way via another epic short squeeze.
https://www.marketwatch.com/story/5-things-tesla-bears-keep-getting-wrong-about-this-stock-2020-01-09?siteid=yhoof2&yptr=yahoo
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Electric Car Stocks Jump as China Signals Lull in Subsidy Cuts
(Bloomberg) -- Shares of Chinese electric-vehicle makers including Warren Buffett-backed BYD Co. jumped after the government signaled it won’t continue reducing subsidies for the industry at the same pace this year.
Miao Wei, the minister for industry and information technology, told an audience in Beijing on Saturday EV-purchase subsidies won’t be cut July 1, like they were on that date last year.
“Please rest assured. There wont be a further cut on July 1 this year,” Miao said in a speech at an industry forum. The audience, which included representatives from major automakers, was thrilled enough to applaud.
Though the minister later clarified his comments, investors and the industry interpreted his remarks as good news for EV manufacturers that were hit by subsidy reductions last year. Sales of new energy vehicles have dropped for six straight months in China since the government scaled back handouts in July.
A few hours after his speech, the minister’s amended statement was aired on China National Radio and the forum’s organizers asked reporters to refer to those comments.
“In order to stabilize market expectations, and ensure the industry’s sustained development, subsidies on new-energy vehicles will stay relatively stable this year, and they won’t be scaled back significantly,” the radio station quoted the minister as saying.
Shares of BYD and competitor BAIC BluePark New Energy Technology Co. surged by their daily trading limit of 10% Shenzhen and Shanghai, respectively.
Tesla Inc., which started delivering locally built electric sedans this month that also qualify for subsidies, rose 2.3% to $488.96 in pre-market New York trading. Chinese sport-utility-vehicle maker NIO Inc., which also trades in the U.S., rose 6.8% to $3.75 pre-market.
The minister didn’t say whether the subsidies will be fully gone by 2021, which is what the government has stated before. Wan Gang, a vice chairman of China’s national advisory body for policy making and an EV pioneer, told the forum that regulators should refrain from making subsidy changes this year so that carmakers can prepare for next year when they will be completely phased out.
China, which began subsidizing EV purchases in 2009 to promote the industry, has been gradually reducing handouts in the past few years to encourage automakers focus on innovating and competing on their own.
https://www.yahoo.com/finance/news/electric-car-stocks-jump-china-051012522.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Here's how Tesla went from Elon Musk's infamous $420 tweet to being worth almost $500 per share
In August 2018, Tesla CEO Elon Musk tweeted that he had secured funding to take Tesla private, at $420 per share — a goofy reference to pot-smoking culture.
The tweet prompted an SEC investigation and an eventual $40 million settlement by Tesla and Musk.
Tesla didn't go private at $420. But after the stock cratered in 2019, it staged an epic year-end rally that put $420 in the past, obliterated short sellers, and gave bulls $500 per share to salivate over.
I've been covering Tesla since 2007, and it's hard to believe that it was just a year ago that CEO Elon Musk dispatched his now-infamous $420 and "funding secured" tweet — and push to take the company private.
That decision wound up costing Tesla and Musk $40 million in an SEC settlement, plus Musk's chairmanship of the company.
But Tesla actually had bigger problems to deal with. Both 2018 and 2019 were tough, as the company struggled through production of the Model 3 sedan and worked feverishly to get a new factory up and running in China.
Somehow, it all came together in late 2019, just as Tesla revealed an absolutely bonkers vehicle, the long-awaited Cybertruck pickup.
Tesla's stock rallied and rallied and then some. By the end of the year, $420 was in the rearview mirror; by January 2020, a $500 share price was in sight.
Here's how it all happened:
On August 7, 2018, Musk was reportedly sitting in his car in Los Angeles when he tapped out the tweet heard 'round the world: "Am considering taking Tesla private at $420. Funding secured."
REUTERS/Hannibal HanschkeTesla shares were actually riding relatively high at the time: $340. But they shot up to almost $390 after Musk's tweet, before settling at $380.
Mike Blake/ReutersMusk's take-private plan collapsed over the next few months. Tesla shares fell to $250 and Musk would eventually face an SEC investigation into whether Musk misled investors. The settlement cost the CEO and the company $40 million, and Musk agreed to restrict his Twitter habit while also forfeiting his chairman title at Tesla.
Markets InsiderWith that catastrophe behind it, Tesla could get back to being a public company trying to hit sales targets from its Model 3 sedan.
Hollis Johnson/Business InsiderThe results of that effort paid off in the third quarter, a historically money-losing Tesla swung to a profit. Shares rallied at the end of 2018, peaking above $360.
TeslaTesla finished 2018 on a strong note, delivering almost 250,000 vehicles, a record. Fourth-quarter earnings also showed a profit, but it was lower than expected.
TeslaThe first half of 2019 was rough for Tesla bulls. The company sold a lot more vehicles and booked much higher revenue, but the losses were staggering. The stock plunged to $190 by mid-year.
Markets InsiderThe second half of 2019 saw Tesla return to profitability, and in October, an epic rally commenced. The carmaker's execution had improved significantly, and Musk's promise to bring a new factory in China online for 2020 had become a reality.
Getty ImagesThe modest momentum that Tesla shares established in October went ballistic for the last two months of the year. The stock blasted through $400 and then $420 by Christmas, and in the first weeks of January, $500 was in sight, with fourth-quarter earnings to come as a fresh dose of rocket fuel.
Thom Baur/ReutersThe insane Tesla Cybertruck had also arrived, proving that Tesla was still able to blow minds with its visionary vehicles.
FREDERIC J. BROWN/AFP via Getty ImagesShort-sellers had enjoyed high times in 2019, but they were crushed as the year closed out. With anywhere from a third to a fifth of Tesla's total share float shorted, frantic covering propelled the rally to new levels.
Spencer Platt/Getty ImageThere were two big takeaways from Tesla's wild 2018 and 2019 stock-market adventure.
REUTERS/Aly SongThe first was that Tesla investing isn't for the weak of knee. An ill-considered tweet from Musk and assorted growing pains on the manufacturing side cost bulls billions of dollars.
Benjamin Zhang/Business InsiderThe second is that in the auto industry, there is no magic formula. If you can build and sell vehicles on schedule and with discipline, revenue and profits should follow.
Matt Debord/Business InsiderThen you can move to scaling up, as Tesla now has in China, and begin to capture unmet demand.
Jae C. Hong/Associated PressThat's how Tesla got from a $420 tweet in August 2018 to a stock price much higher than that today, posting a 2,000% gain since 2010.
Markets InsiderIn retrospect, maybe Musk's idea of going private wasn't so great! Better luck next time, Elon.
https://www.yahoo.com/news/heres-tesla-went-elon-musks-142800856.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTERNATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla powering up to dominate China
Wall Street is thinking big when it comes to Tesla's prospects in China.
The first Model 3 sedans began rolling off the company's Shanghai assembly line last week, setting billionaire entrepreneur Elon Musk's electric-vehicle maker up to grab a tremendous share of the world’s largest auto market.
TESLA DOMINATION OF FORD, GM COSTS SHORT-SELLERS $2B IN 2020
“If Tesla's Model 3 market share in the United States can be replicated in China -- and if this logic extends also to Model Y -- then Tesla's annual volume in China alone would eventually exceed 650,000 units,” wrote Alexander Potter, a senior research analyst at the Minneapolis-based investment bank Piper Sandler, who raised his price target from $423 to $553, or 15 percent above where shares settled Thursday.
Tesla has captured 18.9 percent of the market for luxury sedans in the U.S., selling 183,000 Model 3s in the past 12 months.
A similar position on China would yield an annual sales volume of more than 360,000 Model 3s, Potter said, adding that a similar market share in the SUV market would result in the sale of 290,000 more vehicles.
It will take time, however, for Tesla’s China business to get to those levels. Potter projects 112,000 deliveries in 2020 with that number ramping up to 399,000 in 2022.
Tesla, for its part, has said it hopes to produce 250,000 vehicles at its Shanghai Gigafactory each year.
Dan Ives, managing director at the Los Angeles-based investment bank Wedbush Securities, says that while recent price cuts in China will help, “competition on the electric vehicle front remains fierce in the country, with a number of lower-price alternatives.”
Tesla is making its initial foray into the country as one of its biggest electric-vehicle competitors there bleeds cash. Nio, often referred to as the “Tesla of China,” lost $352.8 million in the third quarter, slashing its cash balance to $274.3 million. The company said continuing to operate depends on its ability to “obtain sufficient external equity or debt-financing.”
Other electric-vehicle makers in the country include the Warren Buffett-backed BYD, Volvo-parent Geely Automotive Group and Volkswagen and GM partner SAIC Motor.
“2020 represents a pivotal year for Musk & Co., as ultimately this will be the year the bulls have been waiting for, with China coming on board and Musk’s grand electric vehicle vision" starting to take hold, he said. There's also a chance, though, that the company "hits another stumble," Ives wrote Thursday, in which case "the bears will come quickly out of hibernation mode." He maintained his “neutral” rating and a $370 price target.
CLICK HERE TO READ MORE ON FOX BUSINESS
https://www.foxbusiness.com/
Tesla shares climbed 15.1 percent this year through Thursday.
https://www.yahoo.com/finance/news/tesla-powering-dominate-china-130728990.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICA , INTER NATIONALENERGYTECHNOLOGYANDCARCOMPANY
Tesla, Inc...............And some say $4000, time will tell the tale.
Tesla Stock Hits High As Elon Musk Gets His Groove On In China
[Investor's Business Daily]
BRIAN DEAGON
,Investor's Business Daily•January 8, 2020
https://finance.yahoo.com/m/8d4147b9-d253-30f7-917b-7e214290ea7a/tesla-stock-hits-high-as-elon.html
Tesla Is the Most Valuable Car Company In America Ever
[Barrons.com]
Al Root
,Barrons.com•January 8, 2020
Tesla's current market capitalization is approaching $83 billion and that exceeds the peak (F) (F) market value of about $81 billion set in 1999, according to Dow Jones Market Data. Tesla's market value is also larger than prebankruptcy (GM) (GM), current General Motors, and pre- (DAI) (DAI.Germany) Chrysler or (FCA) (FCAU). Chrysler and Daimler merged in 1998.
Continue reading
https://finance.yahoo.com/m/61e26335-13a5-3633-a070-f266c504c33a/tesla-is-the-most-valuable.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Target Price on Tesla Inc. Raised
Argus Research has raised its target price on Buy-rated Tesla Inc. (TSLA) to $556 on better than expected 4Q deliveries.
Tesla recently announced it had achieved record production of 104,891 vehicles in 4Q19 and record deliveries of 112,000 vehicles, meeting a goal that the company had forecast at the beginning of last year. Total deliveries for 2019 of 367,500 were 50% higher than in 2018.
We are raising our 2020 EPS estimate to $5.96 from $4.40 to reflect improved economies of scale in 2020 production and delivery results and a better-than-expected ramp up of vehicles produced at the Shanghai factory in China. The 2020 consensus estimate is $5.58.
Our positive stance on the stock, which is up 40% over the past year versus 27% for the S&P 500, assumes ongoing revenue growth from the legacy Model S and Model X, as well as continued strong demand for the new Model 3. The recent (record) production and delivery performance for the fourth-quarter of 2019 highlight the popularity of the Model 3, which accounted for more than 80% of 4Q production.
Despite the recent jump in the stock price, we continue to see significant upside for TSLA shares based on accelerating revenue trends and strong demand for the Model 3.
https://finance.yahoo.com/news/target-price-on-tesla-inc-raised-190640146.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Elon Musk Unveils Tesla Model Y Plan at Shanghai Gigafatory
https://www.yahoo.com/finance/video/elon-musk-unveils-tesla-model-135350969.html
AND...............
Elon Musk unleashes dance moves at Tesla Model Y launch in China
SHANGHAI — Elon Musk showed off his dance moves at the launch of Tesla's Model Y electric sports utility vehicle program at its new Shanghai factory on Tuesday, where the company delivered its first cars built outside the United States to the public.
The $2 billion Tesla factory started delivering cars in just 357 days, a record for global automakers in China. The first 10 customers from the public received their China-made Model 3 sedans on Tuesday.
Billionaire CEO Musk danced enthusiastically on stage at the event, then stripped off his jacket and flung it aside to reveal a T-shirt with a cartoon of the factory. In a tweet, he labelled the video "NSFW" — not safe for work.
He predicted that "ultimately Tesla Model Y will have more demand than probably all the other cars of Tesla combined", with his voice cracking with emotion at times while talking about the progress of the Shanghai factory.
The ceremony was attended by Shanghai Mayor Ying Yong and other senior government officials.
Tesla executives, however, did not provide further details on the progress of the China-made Model Y project. A Tesla representative declined to comment further.
Tesla's shares are trading close to their record high after it beat Wall Street estimates for vehicle deliveries in its fourth quarter. News of production ramp-up in its China factory and upbeat early deposits for its recently launched pickup truck have also supported its share price.
Construction of Tesla's first plant outside the United States began in January and production started in October.
The factory started with a production capacity of 150,000 Model 3 sedans and Tesla aims to push that to 250,000 vehicles a year, including Model Y, in the plant's first phase.
Tesla unveiled its Model Y in March 2019 and said in October that production of the electric compact SUV at its Fremont facility was running ahead of schedule, adding at the time that it expects to launch the model by summer 2020.
It has said that margin expectations are higher for Model Y than Model 3, while production costs are roughly the same.
Tesla's China website estimates the starting price for Model Y vehicles at 444,000 yuan ($63,911.56). It will announce the retail price later, the website says. The China-made Model 3 sedans are priced at 355,800 yuan before subsidies.
Shanghai Vice Mayor Wu Qing said he hoped to see Tesla extend its cooperation with the city and for the car maker to manufacture more models at its Chinese plant.
https://www.yahoo.com/autos/elon-musk-unleashes-dance-moves-140800227.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
SAIC has held of well above previous years pattern of slumping at the end of a year...........Why?...........The Engility acquisition has added value to the overall worth and has made it a strong company both materially and financially.
While enjoy the benefits of this "Trump Induce Economy" hasn't hurt either.
GO SAIC
"PEACE"
SAIC (SAIC) Up 5.1% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for SAIC (SAIC). Shares have added about 5.1% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is SAIC due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
SAIC Q3 Earnings Miss Mark, Rise Y/Y
Science Applications reported third-quarter fiscal 2020 earnings of $1.39 per share, missing the Zacks Consensus Estimate by 3.47%. However, the bottom line improved 2.96% year over year.
Moreover, revenues jumped 38% from the year-ago quarter to $1.6 billion but lagged the Zacks Consensus Estimate of $1.63 billion. Revenues realized from the acquisition of Engility drove the top line. Strong performance of the company’s contract portfolio is a tailwind.
However, adjusting for the impact of acquired revenues, the metric declined 1.5% due to acquisition related dis-synergies.
Quarter in Detail
Net bookings for the quarter were approximately $2.2 billion, reflecting a book-to-bill ratio of approximately 1.4%.
Science Applications’ estimated backlog of signed business deals was approximately $14.5 billion of which, $2.9 billion was funded.
Adjusted operating margin contracted 40 basis points (bps) year over year to 5.8% in the reported quarter.
Adjusted EBITDA of $135 million increased 38%. Adjusted EBITDA margin was flat at 8.3%.
Balance Sheet & Cash Flow
Science Applications ended the quarter with cash and cash equivalents of $162 million, down from $179 million reported in the previous quarter.
Operating cash flow was $116 million, up from $95 million in the sequential quarter. Free cash flow was $116 million compared with $90 million in the preceding quarter.
During the quarter, Science Applications deployed $24 million of capital, $21 million to cash dividends and $3 million to debt repayment.
Guidance
For fiscal 2020, the company expects second-half revenues to be consistent with the first-half figure of $3.6 billion.
For the full fiscal, adjusted EBITDA margin is likely to be at the mid-to-upper-end of the 8.2-8.4% range.
Free cash flow is expected to be at least $425 million for fiscal 2020.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates revision.
VGM Scores
At this time, SAIC has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Notably, SAIC has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
https://finance.yahoo.com/news/saic-saic-5-1-since-163004626.html
GO SAIC
"PEACE"
In the money Jan. 6: Drug, burger makers report multimillion-dollar fundings
..................................
• Savara Inc. has raised about $26.8 million as it develops drugs to treat rare lung diseases. The Austin-based pharmaceutical company announced Dec. 20 it intended to sell more than 9.5 million shares of common stock and pre-funded warrants to buy more than 5.7 million shares in a private placement with "institutional investors," which would generate the $26.8 million, although Savara (Nasdaq: SVRA) still needs to deduct placement agent fees and other offering expenses. The company filed securities paperwork Jan. 2 indicating it had raised the $26.8 million from 18 investors. Savara said Dec. 20 it has also agreed to sell warrants that could allow investors to buy more than 32.5 million additional shares of common stock. The warrants can be exercised by investors two years after the close of this private placement or 30 days after Savara achieves a certain clinical milestone, whichever is earlier. That sale could raise gross proceeds of $48.2 million, according to the company, before deducting expenses and fees. Bain Capital Life Sciences led the placement and Ricky Sun of Bain Capital has joined Savara's board of directors. Investors in the private placement included EcoR1 Capital LLC and Logos Capital. Founded in 2008, Savara is led by CEO Rob Neville and develops drugs for orphan lung diseases such as autoimmune pulmonary alveolar proteinosis and nontuberculous mycobacteria.
https://www.bizjournals.com/austin/news/2020/01/06/in-the-money-jan-6-drug-burger-makers-report.html?ana=yahoo&yptr=yahoo
GO SVRA
"PEACE"
DMOST....."In Like Flint", look towards a huge pay day down the road, in a relatively short time frame.
Are Options Traders Betting on a Big Move in Savara (SVRA) Stock?
Investors in Savara Inc. SVRA need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2020 $5.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?
Clearly, options traders are pricing in a big move for Savara shares, but what is the fundamental picture for the company? Currently, Savara is a Zacks Rank #3 (Hold) in the Medical - Drugs industry that ranks in the Top 23% of our Zacks Industry Rank. Over the last 30 days, one analyst has increased the earnings estimate for the current quarter, while none have dropped their estimates. The net effect has narrowed our Zacks Consensus Estimate for the current quarter from a loss of 52 cents per share to a loss of 49 cents in that period.
Given the way analysts feel about Savara right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
https://finance.yahoo.com/news/options-traders-betting-big-move-143002217.html
GO SVRA
"PEACE"
Tesla Appears to Turn a Corner, Lifting Valuation to $80 Billion
https://www.yahoo.com/finance/news/tesla-appearing-turn-corner-sends-211011700.html
Tesla Ended Its Crazy Year By Shattering its Own Sales Record
https://www.yahoo.com/lifestyle/tesla-ended-crazy-shattering-own-231501655.html
Here's what 4 analysts are saying about Tesla after record delivery numbers sent shares climbing
https://www.yahoo.com/news/heres-4-analysts-saying-tesla-202001244.html
Musk defies skeptics, meets Tesla delivery goal; shares hit record
https://www.yahoo.com/finance/news/tesla-beats-estimates-fourth-quarter-132432556.html
After Tesla's record year in Norway, rivals gear up for 2020
https://www.yahoo.com/finance/news/teslas-record-norway-rivals-gear-091914636.html
Tesla beats Wall Street estimates with record delivery numbers
https://www.yahoo.com/finance/news/tesla-beats-wall-street-estimates-134635762.html
Defying skeptics, Tesla meets delivery goal
https://www.yahoo.com/news/defying-skeptics-tesla-meets-delivery-172846096.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Tesla’s Massive Month of Dutch Demand Buoys Model 3 Deliveries
https://www.yahoo.com/finance/news/tesla-massive-month-dutch-demand-165306943.html
MEANWHILE........................
Layoffs Grip Auto Sector Amid Challenging Operating Backdrop
https://www.yahoo.com/finance/news/layoffs-grip-auto-sector-amid-125012586.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Tesla Scores a Win in China as Local Model 3 Gets Tax Exemption
(Bloomberg) -- Tesla Inc. won exemption from a 10% purchase tax for its China-built Model 3 sedans, a potential boon for Elon Musk’s company as it prepares to begin deliveries of locally manufactured electric cars in the country.
The Model 3 was included on a list of models qualifying for the exemption published by the Ministry of Industry and Information Technology on its website Friday. An exemption means buyers will need to shell out less. Tesla said in October the locally built Model 3 will be priced from about $50,000.
Chief Executive Officer Musk is counting on Tesla’s new China plant to help build on recent momentum for the company in the world’s largest market both for electric vehicles and autos in general. The Model 3 will compete with electric cars from local contenders such as NIO Inc. and Xpeng Motors, as well as global manufacturers including BMW AG and Daimler AG.
The exemption wasn’t completely unexpected, given Tesla’s imported vehicles were already granted one in August. Further helping Tesla, the China-built model this month qualified for a government subsidy of as much as about 25,000 yuan ($3,600) per vehicle.
The company may lower the price of the locally assembled sedans by 20% or more next year as it starts using more local components and reduces costs, people familiar with the matter have said.
https://finance.yahoo.com/news/tesla-scores-win-china-local-065325498.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Tesla Set to Deliver First China-Built Car in Milestone for Musk
(Bloomberg) -- Tesla Inc. will start delivering China-built cars on Monday, a major milestone for Elon Musk’s company as it expands in the world’s largest electric-vehicle market.
The first 15 units of Model 3 sedans assembled at Tesla’s new multi-billion-dollar Shanghai plant -- its first outside the U.S. -- will be delivered to company employees on Dec. 30, capping several months of wins for Musk. The latest came Friday, when the locally built car was included on a list of vehicles qualifying for an exemption from a 10% purchase tax in China.
The shares closed little changed at $430.38 on Friday. The stock has surged since the carmaker reported a surprise profit on Oct. 23, and is now more than double its year low of $178.93 in June.
Chief Executive Officer Musk is counting on the China plant to help build on recent momentum for the company in the world’s largest market both for EVs and autos in general. The Model 3 will compete with electric cars from local contenders such as NIO Inc. and Xpeng Motors, as well as global manufacturers including BMW AG and Daimler AG.
The Shanghai Gigafactory broke ground at the start of this year. Originally just a muddy plot about a 90-minute drive away from Shanghai’s city center, it is now a crucial test of Musk’s bid to keep his carmaker profitable as he bets big on Chinese appetite for electric cars.
With Tesla’s volatile stock price and strained finances, investors will be watching closely how the ramp-up unfolds. The multibillion-dollar investment will be a deciding factor to determine whether Tesla will be able to take on local competitors and fend off challenges by the likes of Mercedes-Benz, BMW and Audi.
Junheng Li, an analyst at JL Warren in New York, noted that the made-in-China Model 3s are not fully manufactured there yet. Tesla is importing parts and assembling them at the facility near Shanghai, with production localization expected later in 2020.
“Localization of suppliers has been very slow,” said Li in an email Friday. Tesla didn’t immediately respond to an inquiry seeking comment.
Although Musk has said he’s never seen a factory built so quickly, the first delivery will come only a day before the end of 2019. Back in April, the CEO predicted Tesla would make at least 1,000 cars a week in Shanghai by the end of the year — a volume the company’s original factory in California spent months trying to hit. He’s also said a weekly rate of 3,000 is a target at some point.
Tesla said in October the locally built Model 3 will be priced from about $50,000. On top of the tax exemption announced Friday, the China-built model this month qualified for a government subsidy of as much as about 25,000 yuan ($3,600) per vehicle.
The company may lower the price of the locally assembled sedans by 20% or more next year as it starts using more local components and reduces costs, people familiar with the matter have said.
The launch will also provide clues about Tesla’s ability to truly go global. The company is planning to follow up with a production facility in Europe.
https://www.yahoo.com/finance/news/tesla-set-deliver-first-china-220702713.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Tesla Patents New Chemistry for Better Batteries
Tesla Motors has applied for a patent for a new additive-mixing battery technology.
The application lists both automotive and energy grid ambitions for the new additive experiments.
Tesla aims to build extremely long-lasting vehicles, and batteries are just one piece of that vision.
Elektrek reports that Tesla is patenting a new chemical additive to improve lithium ion battery technology. The company's solution—literally, it’s electrolytes with additives dissolved inside—works with nickel manganese cobalt compound (NMC) lithium ion batteries and other kinds.
Batteries are a major liability in electric vehicles, both because of the upfront cost of enough batteries to power a vehicle, and concerns over expected lifespan and disposal of those batteries. Tesla has made inroads into battery lifespan over time, and the Tesla Model S was introduced almost as a rolling PR campaign for the idea of electric battery acceptance. In the wake of the controversial Chevy Volt launch in 2011, the 2012-launched Tesla Model S was faster, sleeker, and less ambivalence-inducing in general.
“To further progress the adoption of electric vehicles and grid energy storage applications, it is desirable to develop lithium-ion cell chemistries that offer longer lifetimes at high temperatures and high cell voltages, without significantly increasing cost,” Tesla’s new patent application says. The company says no existing patent or study matches the two-additive system it wants to patent. Tesla also says the technology it’s describing can be generalized to more than just lithium-ion batteries.
It’s key that Tesla's application says “electric vehicles and grid energy storage,” too, indicating that founder and CEO Elon Musk intends to keep working on ideas like storeable solar energy. The idea is that Tesla is experimenting with combinations of two known additives in dozens of combinations of percentages in order to find high-performance two-additive formulas. The patent focuses on dioxazolones and nitrile sulfites, but the application points out that little is understood about how these and other additives work together and in specific kinds of lithium ion batteries. “[T]he identity of certain systems is often based on trial and error and cannot be predicted beforehand,” the patent says.
Existing additives include vinylene carbonate, fluoroethylene carbonate, ethylene sulfate, and lithium difluorophosphate. The patent details choosing candidate additives from one of three groups based on chemical makeup and mixing them at different percentages ranging from .01 percent to 2.0 percent. It’s not clear if this mix-and-match formula approach will be patentable at all—this is just Tesla’s application. But the application itself could be a statement. Tesla has released its patents publicly in the past as a way to increase innovation within the electric car marketplace. This patent application is a road map for experimentation in combining additives to improve battery life.
Specific outcomes are sparse on the ground, but one bullet point far down in the application says that some formulas doubled the number of cycles (or recharges) the battery could take while keeping the same 95 percent capacity retention. By studying many combinations, Tesla hopes to improve the lithium ion battery not just for regular performance but for what Elon Musk has stated is his goal: a million-plus mile battery with a long-lasting vehicle body and powertrain to match. If an LED bulb can last 20 times longer than an incandescent, who’s to say an electric car can’t do the same?
https://www.yahoo.com/news/tesla-patents-chemistry-better-batteries-190200523.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Tesla stock price target raised to $370 from $270 by Wedbush analyst Dan Ives
Tesla Inc. TSLA, +0.45% bulls, hoping for a nice Christmas gift, can be thankful as Elon Musk and his Fremont factory have delivered with strong Model 3 demand and profitability that seems to be on the rise for the fourth quarter, Wedbush analyst Dan Ives wrote in a note Thursday.
The analyst raised his stock price target on the electric car maker by $100 to $370 but maintained his neutral rating on the stock. "For 4Q, both US consumer demand for Model 3 and most importantly European strength should likely drive upside this quarter and enable Tesla to comfortably hit its vehicle delivery guidance of 360K - 400K units for FY19, which represents an increase of 45% to 65% y/y," Ives wrote. "While part of this recent rally has been a massive short covering, it has also been driven by underlying fundamental improvement as the company's ability to impressively not just talk the talk but walk the walk has been noticed by the Street and the optimism around the story has growth markedly from the dark days seen earlier this year."
The company's Shanghai facility is ahead of schedule and will drive growth in China in fiscal 2020 and beyond, said the note. If the company can sustain this level of profitability and demand in Europe and China, it could "open up a new chapter of growth and multiple expansion in our opinion." Ives is retaining his neutral rating while taking a wait-and-see approach to the current demand/profitability spurt, but is moving closer to believing in the turnaround. Tesla shares were up 0.4% premarket and have gained 28% in 2019, while the S&P 500 SPX, +0.18% has gained 29%.
https://www.marketwatch.com/story/tesla-stock-price-target-raised-to-370-from-270-by-wedbush-analyst-dan-ives-2019-12-26?siteid=yhoof2&yptr=yahoo
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Tesla Is the Decade's Best-Performing Auto Company
(Bloomberg Opinion) -- Among the biggest surprises of the past decade was the initial public offering of the Palo Alto company that outperformed every automaker from Detroit to Toyota City to Wolfsburg and is now the undisputed champion of total return, sales growth and long-term shareholder value.
That would be 10-year-old Tesla and its zero-emission, battery electric Model S, X and 3 vehicles.
Co-founder Elon Musk may be the most-ridiculed and penalized chief executive officer since the Securities and Exchange Commission made him pay a $20 million fine for misleading tweets last year. His antics obscure the essential reality that Tesla is gaining confidence among customers and investors because they hold the fossil-free future in their hands, and find it more thrilling and profitable than the latest iteration of hydrocarbon.
The Model 3 now outsells every vehicle from Germany or Japan in the U.S. luxury entry category, and Musk last month said his company had received more than 200,000 pre-orders three days after unveiling the Cybertruck.
Such assurance is the constant element driving Tesla to a record $413 a share this month, or a $73 billion valuation that is greater than all but Toyota ($230 billion) and Volkswagen ($98 billion) among 38 automakers across the globe. Tesla is worth 37% more than General Motors and is almost twice the value of Ford Motor Co. ($37 billion) because nothing gets stock pickers more excited than unprecedented growth. Since the first Model S was purchased in 2012, Tesla sales have increased 52 times while the rest of the industry has averaged 46%.
On Wall Street, most analysts remain unimpressed. Jim Chanos, a frequently cited short seller, told Hedgeye Risk Management last month that his Kynikos Associates “are still bears” and that Tesla is “one of our biggest and our best short positions.” Greenlight Capital, the hedge fund led by David Einhorn, repeatedly insists Tesla's “wheels are falling off.” Einhorn told Bloomberg News in May he will continue his short selling because the electric-car company faces “a stream of unending losses.”
Tesla earned $1.86 a share in the third quarter, exceeding the most optimistic forecast and the consensus estimate for a 24-cent loss.
While Tesla bears get the most attention in media reports -- stories about Tesla that reference Einhorn are at least 10 times more numerous on the Bloomberg terminal than articles on enthusiast Cathie Wood -- stock market bets against Tesla plummeted to the lowest percentage since the company's IPO in 2010, according to data compiled by Bloomberg. People who sell Tesla using borrowed stocks in an arrangement that lets them buy the shares back at lower prices are becoming scarce.
Such Tesla short-selling as a percentage of shares traded is down to 9.2%. The ratio was almost 30% in June and higher than that for any company in the S&P 500 index a year ago.
During the past six months, Tesla appreciated 85% and would be the best performer in the S&P 500 if it was included. It's also No. 1 among its 38 peers in the Bloomberg Intelligence Global Automobile Index.
The prevailing assumption that Tesla is the most volatile auto stock is belied by data showing just the opposite. Tesla gained 22% this year, more than the 14% average for the 10 largest automakers. Tesla was No. 1 last year with a 7% total return (income plus appreciation) when its competitors lost 16%. Over the past two years, Tesla is No. 1 with a 31% return when its peers lost 4%. Since 2017, Tesla is No. 1 with a 99% return when the industry gained 24%.
Anyone who purchased Tesla when it went public in 2010 has a bonanza of 1,190%. The auto industry during the past 10 years appreciated 158%, according to data compiled by Bloomberg.
No automaker can match Tesla's growth. After increasing 10 times since 2014, Tesla revenue will advance an additional 14% in 2019, 21% in 2020 and 18% in 2021, according to 27 analysts contributing their forecasts to Bloomberg. The average growth for the 10 largest auto makers will be 1%, 4% and 3% for the comparable periods. Yet more analysts recommend selling Tesla than buying its shares, and 481 companies in the S&P 500 have more favorable analyst recommendations than Tesla, according to data compiled by Bloomberg.
The declining favorable analyst consensus for Tesla since 2011, from 4.3 to 2.78, is similar to projections about another company 10 years after its IPO: Amazon, the sixth-highest rated company in the S&P 500 today. But at the beginning of 2007, Amazon's consensus rating had declined to 2.5, almost half its current 4.86, according to data compiled by Bloomberg.
The comparison is appropriate, says Cathie Wood, chief executive officer of Ark Investment Management, a Tesla shareholder. Musk faces the same skepticism about his ability to create value that buffeted Amazon CEO Jeff Bezos during Amazon's first decade as a public company.
“The same thing was happening with Amazon for years,” she told CNBC in February. “We were considered crazy, and yet now it seems so obvious. I think the same is going to be true of Tesla.” Wood has a target price of $4,000 a share for Tesla.
https://www.yahoo.com/finance/news/tesla-decades-best-performing-auto-100051206.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY
Tesla short sellers hit $2.43 billion in 2019 losses as automaker's shares reach record high
It’s shaping up to be a terrible holiday season for investors betting against Tesla (TSLA) and Elon Musk.
With shares of the automaker rising 80% since September to hit an all-time high Thursday, losses for those shorting Tesla shares, or betting that Tesla shares will fall in value, have mounted to $2.43 billion in mark-to-market losses during 2019, according to data firm S3 Partners.
Tesla’s rally accelerated this winter after the automaker reported an unexpected profit for the third quarter and said it was moving ahead of its own expectations with the buildout of its Gigafactory in China and the launch of its new Model Y SUV. In the last week alone, Tesla shorts have racked up $1.13 billion in mark-to-losses, writes S3 analyst Ihor Dusaniwsky, adding that the short squeeze pressure on short sellers could add to Tesla’s gains accelerating.
“If Tesla’s rally continues, we should see continued short covering as more shorts reach their P\L pain and risk limits,” he speculated, adding that despite the mounting losses, the number of net shares shorted has only fallen by 0.45% in 2019.
“Tesla shares shorted have not dipped below 20 million shares since mid-2013, but as its stock price keeps hitting historical highs we can expect short covering to accelerate as short mark-to-market losses mount,” Dusaniwsky wrote.
Tesla is up roughly 15% since CEO Elon Musk introduced the Cybertruck at Tesla's design studio in Hawthorne, California this November. (AP Photo/Ringo H.W. Chiu, File)
Tesla is up roughly 15% since CEO Elon Musk introduced the Cybertruck at Tesla's design studio in Hawthorne, California this November. (AP Photo/Ringo H.W. Chiu, File)
Not all Tesla analysts are convinced that the Musk-led company will necessarily be able to meet the higher expectations the automaker has garnered as of late, however. As Credit Suisse analyst Dan Levy noted earlier this week, the success of last quarter will be tough to top.
“Amid this run, expectations for Tesla have likely risen,” he said. “And to the extent a soft datapoint emerges, it could lead to some stock correction.”
As far as Tesla’s story for 2019 is concerned though, it looks like Musk is getting the last laugh of the year at the expense of those betting against him.
https://www.yahoo.com/finance/news/tesla-short-sellers-hit-243-billion-in-2019-losses-as-automaker-hits-record-high-200341094.html
GO TESLA, INC
"PEACE"
$$$$$$ $$$$$$
AMADEINAMERICAENERGYTECHNOLOGYANDCARCOMPANY